Home > Boards > US OTC > Medical - Healthcare > GENEX PHARMACEUTICAL (GENX)
Followed By 538
Posts 17794
Boards Moderated 4
Alias Born 01/02/2005

Friday, February 08, 2008 9:38:45 AM

Re: riskanalyst post# 60

Post# of 110
Here is what the 10-Q states on selling expenses:

"Selling expenses increased by $304,975 to $440,767 for the three month period ended September 30, 2007, from $135,792 for the three month period ended September 30, 2006. The increase in selling expenses is attributable to various expenses associated with marketing the Company’s products and, in particular, increasing acceptance of the Company’s products within the medical community in China. The increase in selling expenses included expenses associated with conducting or sponsoring training programs and seminars for physicians, participating in product trade shows, conducting or sponsoring medical case studies, sponsoring academic research and technical evaluations of the Company’s products, and providing additional training for Company employees. Payment for these expenditures was in large part made through a consulting firm engaged by the Company during the first nine months of 2007 to assist with the management and coordination of these activities. "

It sounds to me like they are ramping up marketing in anticipation of the huge increase in capacity. That sounds like a smart move.

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y